Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2009 May;53(5):751-3.
doi: 10.1161/HYPERTENSIONAHA.108.122846. Epub 2009 Mar 23.

Nanoparticle-mediated drug delivery and pulmonary hypertension

James C Bonner, Jeffrey W Card, Darryl C Zeldin
Editorial

Nanoparticle-mediated drug delivery and pulmonary hypertension

James C Bonner et al. Hypertension. 2009 May.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Schematic representation showing nanoparticle (NP)-mediated delivery of NF-κB decoy oligodeoxynucleotides to block NF-κB-mediated transcription, inflammation, and disease. The possible risks of NP-mediated drug delivery are weighed against the potential benefits.
See this image and copyright information in PMC

Comment on

References

    1. De Jong WH, Borm PJ. Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine. 2008;3:133–149. - PMC - PubMed
    1. Kimura S, Egashira K, Chen L, Nakano K, Iwata E, Miyagawa M, Tsujimoto H, Hara I, Morishita R, Sueishi K, Tominaga R, Sunagawa K. Nanoparticle-mediated delivery of NF-κB decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension. Hypertension. (In press) - PubMed
    1. Perkins ND. Integrating cell-signalling pathways with NF-κB and IKK function. Nature Rev Mol Cell Biol. 2007;8:49–62. - PubMed
    1. Morishita R, Higaki J, Tomita N, Ogihara T. Application of transcription factor “decoy” strategy as means of gene therapy and study of gene expression in cardiovascular disease. Circ Res. 1998;82:1023–1028. - PubMed
    1. Sawada H, Mitani Y, Maruyama J, Jiang BH, Ikeyama Y, Dida FA, Yamamoto H, Imanaka-Yoshida K, Shimpo H, Mizoguchi A, Maruyama K, Komada Y. A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats. Chest. 2007;132:1265–1274. - PubMed

MeSH terms